Please login to the form below

Not currently logged in
Email:
Password:

Clarivate Analytics

This page shows the latest Clarivate Analytics news and features for those working in and with pharma, biotech and healthcare.

Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant

Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant

CIRS is a neutral, independent UK-based subsidiary of Clarivate Analytics, which aims to maintain a leadership role in identifying and applying scientific principles for the purpose of advancing regulatory and

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    Since 2013, the Cortellis Forecast team at Clarivate has applied its proprietary technologies, tools and techniques trusted by its global life sciences customers to produce the Drugs to Watch list, which ... Joan Tur is Cortellis Editor (Forecast Drugs)

  • The changing nature of approvals – what does the future hold? The changing nature of approvals – what does the future hold?

    The 2019 CMR International Pharmaceutical R&D Factbook. Clarivate Analytics, through its Centre for Medicines Research (CMR) International group, recently released the 2019 CMR International Pharmaceutical R&D Factbook –providing insights

  • Pharmaceutical innovation in the APAC region Pharmaceutical innovation in the APAC region

    The full report is free to download and is available from Clarivate Analytics.

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    Sarah Hardison, therapeutic area director from Clarivate Analytics, has also seen an industry response. ... Clarivate Analytics’ Sarah Hardison also acknowledged that industry may focus on cancers with biomarkers, but sees such an approach as an

  • The trials and tribulations of rare opportunities The trials and tribulations of rare opportunities

    Rare disease drugs can also generate high revenues, said Garth Ringheim, Therapeutic Area Director, Clarivate Analytics. ... In other instances where data is available for a large number of patient journeys with the rare disease of interest, predictive

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics